Ticker brief

ILMN ILLUMINA INC

Consumer, Non-cyclical · Biotechnology

last close
$269.42
1 day
+0.0%
14 days
-3.1%
mkt cap
$28.5B
signals 14d
37
authors 14d
23
crowd 14d
-1.7σ
Options inteloptions-surface reads · latest available day per source
metricreadingcontext
IV — ATM 30d71% rich · 100 pctile own 1yIV/HV 1.20×
Skew — 25Δ RR 30d+0.008 83 pctile own 1ycalls bid vs puts (call skew rich)
Net dealer OI (NDOI)+0.54 normal5-session Δ +0.12 (as of 2026-07-06)
OI alarmquietlast alarm 2025-10-31 (z=2.3)
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-15 · now +0.30 (−1 bearish … +1 bullish)
Who spoke23
authorgradetrader scoresignalsmean sent
@Markadiusz45C-2.224-0.24
@PrimeTrading_C-2.184+0.41
@fundmyfundB-0.413+0.07
@1ChartMasterC-2.953+0.65
@benitozB-2.302+0.60
@cnfinancewatchB-1.232+0.45
@AryaFintechC-1.412-0.03
@MartyCharginC-0.562+0.03
@mark_to_mktC-0.671+0.55
@TheLAPurchaserA+0.301-0.70
@NirAoo7C-1.641+0.20
@nikkei_4451B-1.971+0.50
@ANDYmoonC-2.411+0.25
@VistaPResearchC·1+0.35
@Leoskie_LA-1.211+0.45
@MarketMaestro1C-1.301+0.20
@OTR444C+0.131+0.40
@AlexsOptionsC-1.181-0.40
@NickDrendelC-2.371-0.15
@MMatters22596C-0.731+0.40
@artinmemesC+1.041+0.30
@KeithTradeSmithC+1.081+0.65
@MARU_XC+0.061+0.30
Recent signals30of 37 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-15@MARU_X+0.30Ranks six stocks passing a Minervini-style eight-condition trend screen across the S&P 500.+0.6%
2026-10-14@PrimeTrading_+0.45Maps sector leadership, deterioration and rotation while identifying NTRA as the top name to watch.-0.9%
2026-10-13@PrimeTrading_+0.35Maps leadership and rotation toward refiners, life-science tools, cyber and RF semis.-0.6%
2026-10-08@PrimeTrading_+0.35Maps leadership and rotation into healthcare tools, genomics and semiconductors, highlighting DELL.+1.8%
2026-10-08@KeithTradeSmith+0.65AI-driven genomics is presented as an early-stage secular theme with further upside after pullbacks.+1.8%
2026-10-08@artinmemes+0.30The author presents a bullish basket of life-science suppliers positioned around the AI-drug-discovery bottleneck.+1.8%
2026-10-08@cnfinancewatch+0.45Presents a long-term biotech growth basket spanning genomics, AI drug discovery and related platforms.+1.8%
2026-10-08@Markadiusz45-0.20Portfolio update discloses exits, additions, a new long, a stop and current technical views.+1.8%
2026-10-07@PrimeTrading_+0.50Maps sector leadership and rotation, highlighting six 21-day-structure setups.+0.6%
2026-10-07@MMatters22596+0.40Presents a long-term biotech basket organized by genomics and AI drug-discovery layers.+0.6%
2026-10-07@Markadiusz45-0.60Portfolio update discloses an ILMN trim, planned exit and new ANET position.+0.6%
2026-10-06@AryaFintech-0.40Lists the five largest S&P 500 decliners with their daily percentage losses.-1.5%
2026-10-06@MartyChargin-0.45Describes a rough genomics and medical-stock selloff affecting ILMN.-1.5%
2026-10-06@NickDrendel-0.15Calls the genomics move a character change and expects a basing process.-1.5%
2026-10-06@AlexsOptions-0.40Reports a 0.93% winning day and missed historical TXG add and ILMN short signals.-1.5%
2026-10-06@OTR444+0.40Lists stocks identified as technically breaking out; capped at six tickers.-1.5%
2026-10-06@MarketMaestro1+0.20Views ILMN's pause as normal after a strong profitable rally.-1.5%
2026-10-06@fundmyfund-0.65Characterizes the day's genomics and healthcare move as a severe rug pull.-1.5%
2026-10-06@Markadiusz45-0.50Calls genomics candles near-term toppy across ILMN, TXG and ARKG.-1.5%
2026-10-06@MartyChargin+0.50Emphasizes sustained upside performance across four genomics stocks despite valuation concerns.-1.5%
2026-10-06@Leoskie_L+0.45Separates oil-supply dynamics from a genomics basket driven by approvals, reimbursement and shipments.-1.5%
2026-10-06@1ChartMaster+0.65Reports ILMN gapping toward 300 in premarket trading.-1.5%
2026-10-06@Markadiusz45+0.35Portfolio update discloses exiting SNOW while retaining and evaluating several other positions.-1.5%
2026-10-05@AryaFintech+0.35Lists the S&P 500's five largest session gainers with percentage gains.-8.3%
2026-10-05@VistaPResearch+0.35Frames the Nobel Prize in Medicine as illuminating a new bull market for brain-science companies.-8.3%
2026-10-05@ANDYmoon+0.25Names three companies as a genomics-revolution and AI-drug-discovery basket.-8.3%
2026-10-05@nikkei_4451+0.50Presents ILMN and MRNA as beneficiaries of the next AI-drug-discovery theme.-8.3%
2026-10-05@benitoz+0.55Presents a 20-name AI-biology research basket; ticker cap preserves input order.-8.3%
2026-10-05@cnfinancewatch+0.45Long-horizon thesis says AI drug discovery will drive bottleneck demand for wet-lab tools and data foundries.-8.3%
2026-10-05@NirAoo7+0.20Screen lists liquid Stage 2/2A stocks up over 4% with daily close-range above 80%.-8.3%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.